Accumulating evidence has supported the pathophysiological interplay between hypertension and dyslipidemia, which involves oxidative stress, proinflammatory activities, stimulation of the renin-angiotensin-aldosterone system (RAAS), and endothelium dysfunction (9, 10, 14). The gene discussed is REN; the disease is Hypertension.